Welcome to Closing Bell. I'm Scott Wopner live from Post 9 here at the New York Stock Exchange

and this make a breakout begins with Sizzling Tech. The invidious surge continues yet again today.

We're going to ask our experts over this final stretch how much further some of those stocks can run and what it means for the markets

overall there it is there 7% in the meantime the score card was 60 minutes to go and

regulation has more red than green on the board as you see dials negative as is the

s&P. Dow is going backward drag a lot by health care and some of the standout

names they are mostly weaker session as you can see yields they're creeping higher

today the two-year hovering

near 5% again. Consumer confidence, well it was less bad than feared. Some of the

data of late has been pretty good. Yields backing up as a result. You saw what the 10 years doing there too. So

yields are green. We're also watching shares of Texas Instruments today. The

activist firm Elliot taking a stake. That's a story first reported by David

Faber. Stock not doing too much.

That's interesting.

We're gonna ask Stacy Raskon, by the way, about that.

Of course, the star chip analyst

is gonna be right here at Post and I.

We can't wait for that.

And biotech in cement is soaring more than 100% today.

That on positive drug data takes us to our talk of the tape.

The road ahead for the markets with tech once again apparently in the driver's seat.

Let's bring in so far's head of investment strategy,

...